Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?

Area of Science:

• Molecular Biology
• Cancer Research
• Genomics

Background:

• Transcriptional activation involves DNA damage, including DNA double-strand breaks (DSBs), and recruitment of repair proteins.
• Class II topoisomerase TOP2B mediates DSBs during transcriptional activation, particularly in hormone-stimulated prostate and breast cells.
• Improper repair of these DSBs can lead to genomic rearrangements, such as the TMPRSS2-ERG fusion in prostate cancer.

Purpose of the Study:

• To propose a therapeutic strategy exploiting transcription-induced, TOP2B-mediated DSBs in hormone-dependent cancers.
• To investigate the potential of combining hormone-cycling therapy with topoisomerase II poisons or DNA repair inhibitors (PARP1, DNA-PK).

Main Methods:

• The study is primarily hypothesis-driven, proposing a therapeutic strategy based on existing knowledge of transcriptional activation and DNA repair mechanisms.
• It does not detail specific experimental methods but outlines a conceptual approach for therapeutic intervention.

Main Results:

• The hypothesis suggests that overwhelming cancer cells with DSBs through combined therapies could be an effective treatment strategy.
• This approach may be particularly beneficial for slow-proliferating cancers like prostate cancer, where traditional chemotherapies are less effective.

Conclusions:

• Transcription-induced DSBs mediated by TOP2B present a potential therapeutic target in hormone-dependent cancers.
• Combined hormone-cycling therapy with topoisomerase II poisons or DNA repair inhibitors offers a novel strategy to induce lethal DSBs in cancer cells.